key: cord-0956504-pl5v5y8j authors: Ray, A.; Jain, D.; Agarwal, S.; Swaroop, S.; Goel, A.; Das, P.; Arava, S. K.; Mridha, A. R.; Nambirajan, A.; Singh, G.; Arulselvi, S.; Mathur, P.; Kumar, S.; Sahni, S.; Nehra, J.; Nazneen,; BM, M.; Rastogi, N.; Mahato, S.; Gupta, C.; Bharadhan, S.; Dhital, G.; Goel, P.; Pandey, P.; KN, S.; Chaudhary, S.; Keri, V. C.; Chauhan, V. S.; Mahishi, N.; Shahi, A.; R, R.; Gupta, B.; Aggarwal, R.; Soni, K. D.; Nischal, N.; Soneja, M.; Lalwani, S.; Sarkar, C.; Guleria, R.; Wig, N.; Trikha, A. title: Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Biopsies date: 2020-11-16 journal: nan DOI: 10.1101/2020.11.12.20229658 sha: 2165e92014b093fe324be561c422c03bc3aad4df doc_id: 956504 cord_uid: pl5v5y8j Background: The Covid-19 pandemic began in China in December 2019. India is the second most affected country, as of November 2020 with more than a 8.5million cases. Covid-19 infection primarily involves the lung with the severity of illness varying from influenza-like illness to acute respiratory distress syndrome. Other organs have also found to be variably affected. Studies evaluating the histopathological changes of Covid-19 are critical in providing a better understanding of the disease pathophysiology and guiding treatment. Minimally invasive biopsy techniques (MITS/B) provide an easy and suitable alternative to complete autopsies. In this prospective single-center study we present the histopathological examination of 37 patients who died with complications of Covid-19. Methods: This was an observational study conducted in the Intensive Care Unit of JPN Trauma Centre AIIMS. A total of 37 patients who died of Covid-19 were enrolled in the study. Post-mortem percutaneous biopsies were taken with the help of surface landmarking/ultrasonography guidance from lung, heart, liver, and kidneys; after obtaining ethical consent. The biopsy samples were then stained with haematoxylin and eosin stain. Immunohistochemistry (IHC) was performed using CD61 and CD163 in all lung cores. SARS-CoV-2 virus was detected using IHC with primary antibodies in selected samples. Details regarding demographics, clinical parameters, hospital course, treatment details, and laboratory investigations were also collected for clinical correlation. Results: A total of 37 patients underwent post-mortem minimally invasive tissue sampling. Mean age of the patients was 48.7years and 59.5% of them were males. Respiratory failure was the most common complication seen in 97.3%. Lung histopathology showed acute lung injury and diffuse alveolar damage in 78% of patients. Associated bronchopneumonia was seen in 37.5% of patients and scattered microthrombi were visualized in 21% of patients. Immunostaining with CD61 and CD163 highlighted megakaryocytes and increased macrophages in all samples. Immunopositivity for SARS-CoV-2 was observed in Type II pneumocytes. Acute tubular injury with epithelial vacuolization was seen in 46% of the renal biopsies but none of them showed evidence of microvascular thrombosis. 71% of the liver tissue cores showed evidence of Kupfer cell hyperplasia. 27.5% had evidence of submassive hepatic necrosis and 14% had features of acute on chronic liver failure. All the heart biopsies showed non-specific features such as hypertrophy with nucleomegaly with no evidence of myocardial necrosis in any of the samples. Conclusions The most common finding in this cohort is the diffuse alveolar damage with demonstration of SARS-CoV-2 protein in the acute phase of DAD. Microvascular thrombi were rarely identified in the lung, liver and kidney. Substantial hepatocyte necrosis, hepatocyte degeneration, Kupffer cell hypertrophy, micro, and macrovesicular steatosis unrelated to microvascular thrombi suggests that liver might be a primary target of Covid-19. This study highlights the importance of MITS/B in better understanding the pathological changes associated with Covid-19. The beginning of 2020 witnessed the expansion of the COVID-19 pandemic, which began in the Wuhan district of China, in December 2019. In India, the first case was documented on 30 th January 2020. As of 8 th November 2020, the epidemic in India continues to accelerate with 85,41,173 cases and 1,26,525 deaths reported.Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is a positive sense, enveloped, single-stranded RNA virus belonging to the Coronavirus family.(1) The spectrum of COVID-19 infection ranges from asymptomatic disease, mild influenza-like illness, to severe pneumonia, acute respiratory distress syndrome (ARDS), multiorgan failure, and death. Fever is the most common presenting symptom (87.3%) followed by cough (58%) and shortness of breath (38.3%). Radiographic findings include bilateral pneumonia and ground-glass opacities. Roughly 28% of the patients go on to develop acute respiratory distress syndrome and the case fatality rate is around 7%.(2) Other organs have also been found to be variably affected like heart, kidneys, and liver with patients developing complications like arrhythmias, acute kidney injury, and coagulopathy although the pathogenesis is still unclear. In this prospective single-center study, we present the histopathological findings of various organs of 37 patients, who died due to complications of COVID-19 in order to provide insights into the disease pathogenesis, pathological changes in various organ systems and suggestions for treatment. tissue (lung, heart, kidney, liver, brain) submitted was studied and recorded by pathologists having experise in a particular organ system. Special stains (AFB, SM, PAS ) were done to supplement the basic microscopic findings when needed. Immunohistochemistry for CD163 (MA5-11458, Invitrogen, 1:200) and CD61 (MA1-80862, Invitrogen, 1:50) was performed in all lung cores, while SARS-CoV-2 virus was detected by immunohistochemistry using primary antibodies directed against SARS nucleoprotein (B46F clone, Invitrogen, Catalog # MA1-7404, 1:400), in selected lung samples. MITS/B was performed for 37 patients, after obtaining informed consent as detailed earlier. Baseline clinical data were obtained for all patients. Lung tissue cores were taken for 33 patients, liver tissue cores for 29, kidney tissue cores for 11 patients, and heart tissue cores for 15 patients. The mean age of the deceased patients was 48.7 years. 59.5% of them were males. About 95% of them had one or more co-morbidities, most common being hypertension followed by diabetes and chronic kidney disease. 35.1% of the patients presented with severe acute respiratory illness (SARI)and 65.6% of them needed oxygen therapy at presentation. The median duration of hospital stay was 7 days with all patients requiring invasive ventilation during the hospital course. Anemia was seen in 85.3% of patients and lymphopenia in 72% of them. 48.1% of the patients had typical findings of COVID-19 on chest radiograph characterized by peripheral-predominant lowerlobe opacities. Intravenous (IV) broad-spectrum antibiotics were given in all 37 patients, started empirically on day 1 of admission (as per institutional protocol). IV high dose steroids were used in 25 patients (67.5%), while anticoagulation was given to 16 patients (43.2%). Remdesivir was given to 3 patients and 3 patients received tocilizumab. All patients had one or more complications, with respiratory failure being most common, seen in 36 cases (97.3%). Secondary infections and sepsis syndrome, based on clinical and laboratory parameters, were seen in 21 patients (56.7%). Other complications included arrhythmias were seen in 4 patients, coagulopathy and clinically significant bleeding in 4 cases, cytokine release syndrome in 8 cases, acute ischemic stroke in 1 patient, and deep vein thrombosis (DVT) in 1 patient. categorized as organizing DAD also showed normal lung parenchyma in some focal areas. Associated bronchopneumonia was seen in 12 of these patients, the majority associated with the organizing phase of DAD (7/12), with occasional cases co-existing with acute exudative DAD (3/12) and acute lung injury (2/12). Bacterial colonies, indicating superimposed bacterial infection, were observed in one of the cases associated with organizing DAD. Other associated findings observed in these patients include incidental carcinoma (n=2), alveolar hemorrhage (n=2), and pulmonary edema (n=1). In the remaining 7 patients without evidence of acute lung injury or DAD, 3 biopsies showed normal lung parenchyma, 2 showed interstitial chronic inflammatory infiltration, 1 showed tiny lung parenchyma with fibrin deposition, and 1 showed features of acute bronchopneumonia with bacterial colonies. Scattered microthrombi were seen in 21% (7/32) of the patients, all observed in lung biopsies showing organizing DAD (n=6) or acute DAD (n=1). Scattered megakaryocytes and hyperplastic pneumocytes were observed in 7 cases and 5 cases respectively. (Table 2) . Immunostaining for CD163 showed increased macrophages in all samples while CD61 immunostaining highlighted megakaryocytes and microthrombi. Immunohistochemistry for SARS-CoV-2 nucleoprotein was performed in six biopsies and immunopositivity in Type II pneumocyte was observed in one case of acute DAD and none of the organizing DADs. No immunopositivity was observed in endothelial cells, bronchial epithelial cells, or in the hyaline membranes. The most common finding was diffuse acute tubular injury with epithelial vacuolization seen in 46% of the patients (Figure 4) . None of the cases demonstrated microvascular thrombosis. Other histological findings noted were of the underlying kidney disease including advanced diabetic glomerulosclerosis (n=1) and early diabetic/hypertensive changes (n=1). Two patients had history of renal transplantation, of which one had a concomitant chronic active T cell and antibody-mediated rejection and the other had focal segmental glomerulosclerosis. . (Table 3) : Liver biopsy cores were obtained from 29 of these 37 patients. In 8 patients (27.58%) acute submassive hepatic necrosis was identified, while in 4 (13.79%) biopsies features of acute on chronic All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint liver failure (ACLF) were identified with the presence of hepatic necrosis ( Figure 5 ). Four of the biopsies showing acute hepatic necrosis also showed prominent microvesicular steatosis. In one of the liver biopsies showing features of ACLF, the histological features were like an acute exacerbation of autoimmune inflammation. However, the most common histological finding was Kupffer cell hypertrophy seen in 21 (72.41%) biopsies. In 3 biopsies (10.3%) there were features of non-cirrhotic portal fibrosis (NCPF), in the form of portal vein thrombosis in 2 biopsies with or without focal sinusoidal microthrombi. Portal inflammation, interface hepatitis, or lobular necroinflammatory activity were not prominent in any of our cases. While significant portal mononuclear cell infiltrates were identified in 13 (44.82%) biopsies, in only 3 biopsies the portal inflammation was dense, while in only 4 of these biopsies the portal inflammation was moderate. Lobular inflammation was identified only in 5 (17.24%) cases ( Figure 6 ). In 4 biopsies (13.79%) there was centrizonal hemorrhagic necrosis, histologically suggestive of heart failure. Macrovesicular steatosis in zone 3 and zone 2 were identified in 4 (13.79%) and diffuse macrovesicular steatosis was noted in one biopsy ( Figure 6 ). Out of the liver biopsies showing macrovesicular steatosis, two of these patients had a history of chronic hypothyroidism, while all of them also got steroids as part of their management regimen during the current hospital course of the COVID-19 related episode.In two of the biopsies from patients with hypothyroidism, we also identified prominent nuclear glycogenization ( Figure 6 ). Liver biopsy cores from 4 of these deceased were within normal histological limits. The biopsies showing hepatic necrosis had a varied pattern. while zone 3 predominant necrosis was seen in 8 biopsies ( Figure 6H ), diffuse transacinar necrosis was noted in 2 and focal irregular necrosis pattern was identified in 3 of these biopsies. Other features of hepatocyte damage viz. ballooning, acidophil bodies,and Kupffer cell hyperplasia were also prominent in most of the liver biopsies, except the histologically normal biopsies ( Figure 6 ). Intracanalicular and hepatocyte cytoplasmic cholestasis were identified in 7 biopsies (24.13%) and ductular cholestasis was identified in one biopsy with other features of associated sepsis-related changes. All the heart biopsies showed non specific histopathological features like mild hypertrophy with nucleomegaly of the cardiac myocytes. None of the biopsy samples showed evidence of myocyte damage or necrosis, which is the hall mark of myocarditis. However only one biopsy showed presence of few lymphocytic infiltrtation in the interstitium without myocyte damage indicative of borderline myocarditis. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint Minimally invasive autopsies (MIA) or MITS/B are a simplified method of conducting postmortem sampling, originally devised to investigate the causes of death in low-resource settings. Due to the potential risks associated with conducting traditional post-mortem examinations in COVID-19 patients, this method has been adopted to study morbid pathological changes in COVID-19 patients. (4, 5) This method besides being effective(6,7) also has the added advantage of being more acceptable(8) and less time-consuming than elaborate autopsies. In this series of post-mortem samples from 37 patients from a single tertiary care center in India, we studied the morbid pathological changes in COVID-19 patients. has been observed previously (12) suggesting that this may be a pathological manifestation of the virus itself. The incidence of vascular changes were only 21% ,which was less than that reported. (12, 13) Several factors could have contributed to this observation including regular use of anticoagulants in the cohort as a part of national policies(14), lower thrombotic complications in the population studied (due to genetic (15) or climatic factors (16)) as well as sampling errors. We were able to demonstrate All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint SARS-CoV-2 nucleoprotein in one case among 6 cases tested in Type 2 pneumocytes using immunohistochemistry. A recent study has demonstrated specific detection of SARS-CoV-2 in areas of acute DAD and the hyaline membranes while areas of organizing DAD did not show detectable viral antigen indicating viral clearance in the later stages of ARDS (17) . In support of this observation, we observed immunostaining for viral antigen in areas of acute DAD. Histopathological examination of liver in COVID-19 patients had typically revealed mild steatosis, focal hepatic necrosis, Kupffer cell hyperplasia, and sinusoidal dilatation as reported in literature. (4, 18, 19) Less commonly reported findings include inflammation of portal/sinusoidal tracts, (4, 18, 20) portal/sinusoidal thrombosis, (21) acute hepatitis (20) and acute endothelitis. (19, 20) In perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint Renal histopathology in COVID-19 is reported to show changes including prominently acute tubular injury (more prominent in the proximal tubules)(18,24-28), arteriosclerosis (18) or glomerulosclerosis (29) (both as features of underlying comorbid conditions like hypertension), focal segmental glomerulosclerosis with a collapsing phenotype (25-27) and tubulointerstitial inflammation(24,26). Renal vascular changes reported are relatively less common and include fibrin thrombi (27,30), thrombotic angiopathy(29), and lymphocytic endothelitis (19) . In our cohort of patients, the most common finding on renal histopathology was acute tubular injury and pre-existing renal conditions were only evident in 18%. None of the cases showed significant vascular changes. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint Tables: Table 1 Demographic preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint Supplementary: perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 16, 2020. ; https://doi.org/10.1101/2020.11.12.20229658 doi: medRxiv preprint Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies Feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patients Ultrasonographic autopsy (echopsy): a new autopsy technique Multimodality minimally invasive autopsy--a feasible and accurate approach to post-mortem examination Willingness to Know the Cause of Death and Hypothetical Acceptability of the Minimally Invasive Autopsy in Six Diverse African and Asian Settings: A Mixed Methods Socio-Behavioural Study Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Progression to Fibrosing Diffuse Alveolar Damage in a Series of 30 Minimally Invasive Autopsies with COVID-19 Pneumonia in Wuhan The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment The Spectrum of Histopathologic Findings in Lungs of Patients with Fatal COVID-19 Infection Geographical & seasonal variation in COVID-19 related mortality Seasonal variation in the frequency of venous thromboembolism: An updated result of a meta-analysis and systemic review Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series Endothelial cell infection and endotheliitis in COVID-19 COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19 -PubMed